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Centre for Public 
Health
As our population grows older, the risk of developing cognitive
disorders increases and is a major public health challenge.1 Mild
Cognitive Impairment (MCI) is described as a transitional stage
between the expected cognitive decline of normal ageing and
that of dementia2 and is suggested to be the optimum time point
for preventative intervention3,4. Nutrition and cognitive decline
has been examined in terms of a range of nutrients/dietary
patterns, investigating the role that single nutrients, such as n-3
PUFA5 as well as whole diet interventions, such as the DASH
diet6, a ketogenic diet7 or the Mediterranean diet8 may have.
Therefore, a rationale exists to systematically review the dietary
intervention studies in the literature among this patient group.
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Background
To examine the effect of diet, either alone or in combination with
lifestyle and/or cognitive strategies, on cognitive health outcomes
in patients with MCI.
• Diagnosis of Mild Cognitive Impairment
• Community dwelling participants
• Randomised Controlled Trial
Inclusion  
Criteria
• Diagnosis of dementia or any other form of 
cognitive impairment other than MCI
• Participants with psychiatric problems e.g. 
depression or any significant medical 
comorbidity
• Individuals who are hospitalised, in a 
rehabilitation or long term care facility
• Pilot studies
Exclusion 
Criteria
• Incident Dementia/Alzheimer's Disease (AD)
Primary 
Outcome
• Validated cognitive measure 
(neuropsychological and/or cognitive test)
• Data on quality of life, adverse events and 
biomarker analysis (e.g. structural MRI or 
amyloid imaging) if available 
Secondary 
Outcome
Objective
Methods
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Results
* indicates statistically significant difference between intervention and control/placebo at study 
completion (p<0.05)
Records identified  = 2130
Records after duplicates 
removed = 1480
Titles and abstracts 
screened = 1480
Excluded = 1447
Full text articles screened 
= 33
Studies included in 
analysis = 12
Discussion and Conclusion
Diet supplementation, with either Vitamin E14 or Ginkgo
Biloba12, had no statistically significant effect on progression
from MCI to dementia and/or AD. There was heterogeneity in
the results for cognitive function. Some studies showed
improvements in a few of the cognitive tests used but not all,
with some of the improvements observed not being
maintained until intervention completion. The studies which
investigated B vitamins and folic acid 10,11 and cocoa
flavanols16 showed the most consistent results in terms of
cognition.
The mixed evidence may be explained by the heterogeneity of
studies included, on the basis of:
• the variation in cognitive outcome measures used
• differences in the diet intervention type (supplements vs
single food products vs dietary patterns)
• variations in sample size and duration of intervention
• the small number of dietary intervention studies conducted
These factors make it difficult to provide conclusive evidence
to support the effect of diet on cognitive outcomes.
Nonetheless, the review highlights the need for well-designed,
robust RCTs to further explore the role of diet in cognitive
decline.
Database search: Ovid 
MEDLINE, EMBASE, 
PsycINFO, Web of science 
and Scopus
Reference Intervention Cognitive outcome 
measured
Ma 
(2016)10
Folic Acid (400 μg) (n=180, 
6 months)
Memory*; Visuospatial skills*
de Jager
(2012)11
0.8mg folic acid, 0.5mg vitamin 
B12, 20mg vitamin B6 (n=266, 2 
years)
Memory*; Executive function*;
Global cognition
Dekosky
(2008)12
Gingko Biloba (120-mg) (n=482, 
6.1 years)
Diagnosis of Dementia
Lee 
(2013)13
n-3 fatty acids (430 mg of DHA and 
150 mg of EPA) (n=36, 12 months)
Memory*; Executive Function; 
Attention; Visuospatial Skills; 
Psychomotor speed; Global 
cognitive function 
Petersen 
(2005)14
Vitamin E (2000 IU) (n=769, 3 
years)
Development Alzheimer’s 
disease; Memory; Executive 
Function; Language; Visuospatial 
skills; Overall Cognitive Function
Krikorian 
(2010)15
Chromium Picolinate (1000 mcg) 
(n=26, 12 weeks)
Memory; fMRI*
Desideri
(2012)16
Cocoa Flavanols
(990mg/520mg/45mg) (n=90, 8 
weeks)
MMSE; Trail making test, Part A 
and B*; Verbal fluency test*
Krikorian 
(2010)17
Concord grape juice (n=12, 12 
weeks)
Memory* (verbal learning only) 
Krikorian 
(2010)18
Wild blueberry juice (n=9, 12 
weeks)
Memory* (V-PAL test only) 
Horie 19
(2016)
Nutritional counselling (healthy 
eating/calorie restriction) (n=80, 12 
months)
Memory; Executive Function; 
Language; Psychomotor Speed
Bayer-Carter 
(2011)20
High–saturated fat/high–GI Vs 
low–saturated fat/low–GI diet 
(n=49, 4 weeks)
Memory; Executive Function; 
Motor Speed; AD Biomarkers* 
(CSF Aβ42 only)
Krikorian 
(2012)7
High carbohydrate Vs very low 
carbohydrate diet (n=23, 6 weeks)
Memory 
